Pharmaceutical Excipients Market to Gain $12.24 Bn by 2028 with Booming CAGR Value of 6.6%

Global Pharmaceutical Excipients Market growth is driven by the growing generics market and increasing product launches. BASF SE and Roquette Frères- are the notable players in global market.

New York, Dec. 01, 2022 (GLOBE NEWSWIRE) — According to The Insight Partners new research study on “Pharmaceutical Excipients Market Size, Share, Growth, Trends and Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Clinical Indication, Functionality, Application, End User, and Geography,” the global market is expected to grow from USD 7.82 billion in 2021 to USD 12.24 billion in 2028; it is estimated to grow at a CAGR of 6.6% from 2022 to 2028.

Download Sample PDF Brochure of Pharmaceutical Excipients Market Size – COVID-19 Impact and Global Analysis with Strategic Insights at:

Global Pharmaceutical Excipients Market Report Scope, Segmentations, Regional & Country Scope:

Report Coverage Details
Market Size Value in USD 7.82 Billion in 2021
Market Size Value by USD 12.24 Billion by 2028
Growth rate CAGR of 6.6% from 2022 to 2028
Forecast Period 2022-2028
Base Year 2021
No. of Pages 570
No. of Tables 662
No. of Charts & Figures 127
Historical data available Yes
Segments covered Type, Clinical Indication, Functionality, Application, End User
Regional scope North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scope US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Companies Covered JRS PHARMA GmbH & Co KG, Roquette Freres SA, BASF SE, Evonik Industries AG, AshLand Inc, Archer-Daniels-Midland Co, The Dow Chemical Co, The Lubrizol Corp, Avantor Inc, and MEGGLE GmbH & Co KG., Univar Solutions Inc

Global Pharmaceutical Excipients Market: Competition Landscape and Key Developments

JRS PHARMA GmbH & Co KG, Roquette Freres SA, BASF SE, Evonik Industries AG, AshLand Inc, Archer-Daniels-Midland Co, The Dow Chemical Co, The Lubrizol Corp, Avantor Inc, and MEGGLE GmbH & Co KG., Univar Solutions Inc. are a few of the key companies operating in the global pharmaceutical excipients market. These companies adopt product innovation strategies to meet the evolving customer demands, allowing them to maintain their brand name in the global pharmaceutical excipients market.           

Pharmaceutical excipients are substances other than active pharmaceutical ingredients (APIs) that have been appropriately evaluated for safety and are intentionally included in a drug delivery system. 

Inquiry Before Purchase:

Global Pharmaceutical Excipients Market Growth Factors:

Growing Generics Market

According to Food and Drug Administration (FDA), in the US, about 9 out of the 10 prescriptions have generic drugs. Governments of developing countries are focusing on reducing healthcare costs by boosting the production of generic drugs. For instance, in November 2008, the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India launched Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) to make quality generic medicines available at affordable prices. The scheme focused on dedicated outlets known as Janaushadhi Kendras, offering generic medicines at affordable prices. Till 2021, 8,012 Janaushadhi Kendras were functional across India. In addition, many drugs are on the brink of losing their patents. Generic drug companies can produce replicas of branded drugs when patents of original drugs expire. The replicas can cost up to 80% less than the originals. Therefore, the generics industry has witnessed remarkable growth in the last decade as the patents of many branded drugs have expired, with companies achieving above-average shareholder returns.

Excipients are an integral component of pharmaceutical products that determine the structure of dosage type and its role in delivering drugs. Excipients significantly affect the process ability, aesthetics, efficiency, and patient compliance with the dosage form. Thus, the use of excipients in a formulation requires an assurance and a clear understanding of their quality, safety, and performance attributes. The principal role of excipients is to support patient acceptability, enhance stability, bioavailability, and assist in the effectiveness.

Thus, the rise in the sale of generic drugs across the world propels the demand for pharmaceutical excipients used in manufacturing generic drugs.

Have a Question? Speak to Research Expert:

Rising Demand and Emphasis on Co-Processed Excipients

Formulation scientists have recognized that single-component excipients do not always provide the requisite performance to allow certain APIs to be manufactured adequately. These scientists focus on the production of co-processed and multifunctional excipients with enhanced performance.  Co-processed excipients are a mixture of two or more existing excipients at the sub-particle level, offering substantial benefits of the incorporated excipients and minimizing their drawbacks. These multipurpose excipients have dramatically reduced the number of incorporating excipients in the tablet. The co-processed excipients are used to improve the drug’s flow, disintegration, lubrication, and compressibility. The excipients also simplify the formulation process and make it cost-effective. They are increasingly used to convert complicated and labor-intensive formulation processes, such as wet granulation, to quick direct-compression processes, without affecting the final product quality or performance. Co-processed excipients play a crucial role in the creation of a stable, result-oriented drug delivery system with enhanced chemical, physical, and mechanical properties.

processed excipients, the companies are focusing on developing co-processed excipients for drug formulations. For instance, in July 2021, DFE Pharma launched a co-processed excipient, Pharmacel sMCC 90, silicified microcrystalline cellulose (MCC). It has been developed as the synergistic solution for challenging oral solid dosage formulations. A co-processed excipient is a promising tool in the production of pharmaceutical products. Existing co-processed adjuvants cannot fulfill all the needs for the preparation of various novel formulations. There is also enough space for the production of new co-processed excipients to satisfy the demand of the pharmaceutical industries, which is expected to act as an opportunity for the growth of the pharmaceutical excipients market during the forecast period.

Directly Purchase “Single User License” of Pharmaceutical Excipients Market Growth Report (2022-2028) at:

Browse Related Reports:

Sugar Based Excipients Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – by Product (Actual Sugars, Sugar Alcohols, Artificial Sweeteners); Type (Powders/Granules, Direct Compression Sugars, Crystals, Syrups); Functionality (Fillers and Diluents, Flavoring Agents, Tonicity Agents, Other Functionalities); Formulation (Oral Formulations, Parenteral Formulations, Topical Formulations, Other Formulations)

Nasal Drug Delivery Technology Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – By Systems ( Unit Dose, Bi-Dose, Multi Dose ); Containers ( Pressurized Containers, Non-Pressurized Containers ); Dosage Form ( Nasal Powders, Nasal Gels, Nasal Drops and Liquids, Nasal Spray, Others ); Therapeutic Application ( Allergic and Non-Allergic Rhinitis, Nasal Congestion, Vaccinations, Other Applications ); End User ( Hospitals, Home Health Care )

Ocular Drug Delivery Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers) and Geography

Blood Compatible Polymers Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Polyvinylchloride, Polytetrafluoroethylene, Polyethersulfone, Polyethylene, Polyetheretherketone, Polysulfone, Poly Propalene); Application (Biomedical and Blood Contacting Devices, Dental, Drug delivery) and Geography

Needle Free Drug Delivery Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Technique (Inhalers, Transdermal Patch, Jet Injectors, Novel Needle Free); Application (Pediatric Injection, Insulin Delivery Devices, Vaccine Delivery Devices, Others) and Geography

Implantable Drug Delivery Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type (Contraceptive Implants, Spinal Implants, Brachytherapy Seeds, Drug-Eluting Stents, Bio-absorbable Stents, Intraocular Stents, and Infusion Pumps), Technology (Biodegradable Implants and Non-biodegradable Implants), and Application (Ophthalmology, Oncology, Cardiovascular, Birth control, Opioid-Use Disorder, and Others)

Biomaterials Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – by Type (Metallic, Ceramic, Polymers, Natural); Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology)

Next Generation Implants Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – by Material ( Metal and Alloys, Ceramics, Polymers, Biologics and Others ); Application ( orthopedic implants, Cardiovascular implants, ocular implants, Dental implants and others. )

Absorbable Sutures Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – by Product Type (Catgut, Polymer Chemistry, Collagen Suture, Other Product Types); Application (Cardiovascular Surgeries, General Surgeries, Orthopedic Surgeries, Gynecological Surgeries, Ophthalmic Surgeries, Other Applications); End User (Hospitals, Ambulatory Surgical Centers (ASCS), Clinics and Physician Offices) and Geography

Bioabsorbable Stents Market Forecast to 2028 –  Covid-19 Impact and Global Analysis – by Biomaterial (Polymeric Stents, Metallic Stents, Natural); Application (Coronary Artery Disease, Peripheral Artery Disease); End User (Hospital, Cardiac Centers)

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release:

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. takes no editorial responsibility for the same.